This presentation looks at the dynamic landscape of therapeutic antibody development, focusing on next-generation immuno-oncology therapeutics that target checkpoint inhibitors and incorporate the ...

With the global market expected to hit $479 billion by 2028 and around 10 therapeutic antibodies gaining approval annually in ...

Scientists have developed numerous monoclonal antibody (mAb)-based therapies for the treatment of ailments, such as cancer, autoimmune disorders, and infectious diseases. To produce these ...

Israel-based AION Labs, an AI-enabled drug discovery partnership between global pharma and tech companies, announced the launch of a new startup company CombineAble.AI, which will speed up the ...

Accelerate your therapeutic antibody programs, from early concept to IND submission, with Pharmaron’s fully integrated discovery and development services. The platform supports monoclonal, bi-specific ...

From a chemistry, manufacturing, and controls (CMC) perspective, ADCs present unique hurdles. “ADCs introduce unique challenges across areas like process and purification development, analytical ...

From payload optimization to integrated GMP manufacturing, companies aim to elevate oncology ADCs to standard of care.

BEIJING--(BUSINESS WIRE)--Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (“Biocytogen”, HKEX: 02315) today announced the launch of a new sub-brand, RenBiologics™, to represent the company’s antibody ...

An ambitious project led by Vanderbilt University Medical Center investigators aims to use artificial intelligence technologies to generate antibody therapies against any antigen target of interest.

In the last few years, multispecific antibodies, such as bispecific, trispecific, and tetraspecific antibodies, have become the breakthrough stars in antibody therapeutics. Compared with conventional ...

Collaboration leverages Converge Bio's proprietary generative AI to design and optimize novel tri-specific antibodies for oncology needsAI-driven ...

The acquisition will add Belgium-based chromatography operations and a team of over 50 employees to Merck.